USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: SEQUELA
Address: 6508 Old Floydsburg Road
Pewee Valley, KY
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $996,069.00 2
SBIR Phase II $2,589,558.00 2

Award List:

A Uroguanylin Based ELISA for Salt Sensitivity

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Stephen L. Carrithers
Award Amount: $403,642.00
Abstract:
DESCRIPTION: This proposal is submitted in response to the program announcement PA-03-123 "Development of diagnostic screening test for salt sensitivity (SBIR/STTR)" from the National Institute of Diabetes and Digestive and Kidney Diseases. The overall hypothesis of our laboratory is the principle… More

A Test for Salt Sensitivity in People with Essential Hypertension

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $914,453.00
Abstract:
DESCRIPTION (provided by applicant): Project Summary: In Phase I we developed a model system and a prototype Salt Sensitivity Assay to establish proof-of-principle . In Phase II we propose the evaluation of the prototype that will quantitatively measure our biomarker in the target… More

Biomarker for Early Detection of Chronic Kidney Disease

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Stephen L. Carrithers
Award Amount: $592,427.00
Abstract:
DESCRIPTION (provided by applicant): This proposal is submitted in response to the program announcement PA-09-080, Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) and intende d to be directed to the NIDDK, with a… More

BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Stephen L. Carrithers – 502-432-7712
Award Amount: $1,675,105.00
Abstract:
DESCRIPTION (provided by applicant): There are an estimated 26 million Americans with early chronic kidney disease (CKD). Early diagnosis and treatment are the only cost-effective means to reverse this growing problem. NIH recognizes the challenge to diagnose CKD early during its initiation and… More